Results 21 to 30 of about 116,097 (352)
Pre‐eclampsia‐like syndrome induced by severe COVID‐19: a prospective observational study
BJOG: an International Journal of Obstetrics and Gynaecology, 2020 To investigate the incidence of clinical, ultrasonographic and biochemical findings related to pre‐eclampsia (PE) in pregnancies with COVID‐19, and to assess their accuracy to differentiate between PE and the PE‐like features associated with COVID‐19.
M. Mendoza +10 more
semanticscholar +1 more source
Platelet Indicies in Pre-eclampsia and Eclampsia [PDF]
National Journal of Laboratory Medicine, 2018 Introduction: Activation of platelets due to defective placental trophoblastic invasion in the pathophysiology of pre-eclampsia and eclampsia is known. The changes in the platelet parameters and its relevance are discussed in this article.
Deepak Donthi, Udaya kumar, Arun Gopi
doaj +1 more source
BMJ Open, 2022 Objectives To investigate the impact of pre-eclampsia on the future cardiovascular risk in Finnish womenDesign A registry-based nationwide controlled cohort study.Setting Women hospitalised for pre-eclampsia in 1969–1993 and control women with a history ...
Mika Gissler +5 more
doaj +1 more source
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2019 Pre‐eclampsia (PE) is a multisystem disorder that typically affects 2%–5% of pregnant women and is one of the leading causes of maternal and perinatal morbidity and mortality, especially when the condition is of early onset.
L. Poon +16 more
semanticscholar +1 more source
Jurnal Profesi Medika, 2017 Pre-eclampsia/Eclampsia is the second largest cause of maternal death after postpartum hemorrhage. There are some risk factors that influence the occurrence of pre-eclampsia/eclampsia.
Syifa Aulia Luthfiyani +2 more
doaj +1 more source
Neurologic Clinics, 1994 This article defines and then delineates pre-eclampsia and eclampsia, reviewing the clinical features, neurologic manifestations, and underlying causes. There is a review of the pathophysiology including hypertension, coagulopathy, and cerebral pathology including newer findings involving immune system abnormalities.
P W, Kaplan, J T, Repke
openaire +2 more sources
Antiplatelet agents for preventing pre-eclampsia and its complications.
Cochrane Database of Systematic Reviews, 2019 BACKGROUND Pre-eclampsia is associated with deficient intravascular production of prostacyclin, a vasodilator, and excessive production of thromboxane, a vasoconstrictor and stimulant of platelet aggregation. These observations led to the hypotheses that
L. Duley +4 more
semanticscholar +1 more source
Comparison Study of Coagulation Profile in Normal Term Pregnancy and Pregnancy Induced Hypertension [PDF]
National Journal of Laboratory Medicine, 2020 Introduction: Pregnancy Induced Hypertension (PIH) is one of the commonest medical disorders in pregnancy, which is divided into three categories: gestational hypertension, preeclampsia and eclampsia.
Garima Dundy +3 more
doaj +1 more source
Hypertension in Pregnancy, 2020 Objective: To determine whether family history of pre-eclampsia and cardiovascular disease is consistently associated with the occurrence of pre-eclampsia sub-phenotypes and fetal growth restriction (FGR).
Norma C Serrano +6 more
doaj +1 more source
Scientific Reports, 2021 The aim of this study is to establish the expression of ATP-sensitive potassium channels(KATP) in human umbilical arteries with severe pre-eclampsia.
Benlan Yin +7 more
doaj +1 more source